🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/08/2002 | 51,07 | 51,34 | 49,63 | 50,15 | -2,30% | 3,34% | 5.145.680 |
| 22/08/2002 | 49,43 | 51,53 | 49,24 | 51,34 | +3,70% | 4,63% | 7.231.829 |
| 21/08/2002 | 48,55 | 49,74 | 48,51 | 49,50 | +2,45% | 2,54% | 5.145.785 |
| 20/08/2002 | 48,23 | 49,14 | 48,14 | 48,32 | -1,21% | 2,08% | 4.040.564 |
| 19/08/2002 | 47,71 | 49,43 | 47,71 | 48,91 | +2,52% | 3,60% | 4.838.721 |
| 16/08/2002 | 48,26 | 48,31 | 47,35 | 47,71 | -1,15% | 2,00% | 5.121.471 |
| 15/08/2002 | 48,66 | 49,33 | 47,54 | 48,26 | -1,00% | 3,69% | 5.719.460 |
| 14/08/2002 | 46,85 | 48,95 | 46,17 | 48,75 | +2,84% | 5,93% | 7.758.868 |
| 13/08/2002 | 48,28 | 49,04 | 47,34 | 47,40 | -3,06% | 3,52% | 5.493.406 |
| 12/08/2002 | 47,85 | 49,22 | 47,81 | 48,90 | +0,45% | 2,95% | 4.865.130 |
| 09/08/2002 | 47,95 | 49,17 | 47,31 | 48,68 | +1,33% | 3,88% | 7.465.952 |
| 08/08/2002 | 46,94 | 48,18 | 46,72 | 48,04 | +2,86% | 3,11% | 8.251.952 |
| 07/08/2002 | 45,11 | 46,75 | 44,57 | 46,71 | +4,53% | 4,82% | 6.080.391 |
| 06/08/2002 | 44,11 | 45,78 | 44,00 | 44,69 | +2,83% | 4,04% | 6.195.462 |
| 05/08/2002 | 45,56 | 45,73 | 43,27 | 43,45 | -4,85% | 5,38% | 6.173.663 |
| 02/08/2002 | 45,18 | 47,08 | 45,07 | 45,67 | -0,19% | 4,46% | 7.029.670 |
| 01/08/2002 | 47,10 | 47,10 | 45,48 | 45,75 | -3,33% | 3,44% | 7.017.513 |
| 31/07/2002 | 46,09 | 47,33 | 45,10 | 47,33 | +2,25% | 4,84% | 7.520.867 |
| 30/07/2002 | 45,56 | 46,85 | 45,32 | 46,29 | +0,10% | 3,35% | 7.584.795 |
| 29/07/2002 | 45,31 | 46,35 | 44,78 | 46,24 | +5,35% | 3,45% | 10.087.419 |
| 26/07/2002 | 42,19 | 43,89 | 41,69 | 43,89 | +3,46% | 5,22% | 8.846.482 |
| 25/07/2002 | 40,27 | 42,98 | 39,94 | 42,42 | +4,37% | 7,54% | 12.004.002 |
| 24/07/2002 | 37,31 | 41,04 | 36,79 | 40,65 | +9,09% | 11,38% | 14.185.833 |
| 23/07/2002 | 37,84 | 38,65 | 36,74 | 37,26 | -2,40% | 5,04% | 12.019.826 |
| 22/07/2002 | 39,41 | 40,51 | 37,21 | 38,18 | -3,59% | 8,35% | 12.743.890 |
| 19/07/2002 | 40,09 | 40,71 | 39,55 | 39,60 | -1,19% | 2,88% | 12.485.662 |
| 18/07/2002 | 41,63 | 42,23 | 40,08 | 40,08 | -5,62% | 5,18% | 8.992.574 |
| 17/07/2002 | 42,56 | 43,65 | 41,52 | 42,46 | +1,11% | 5,02% | 10.095.070 |
| 16/07/2002 | 42,70 | 43,61 | 41,75 | 41,99 | -3,70% | 4,36% | 9.176.602 |
| 15/07/2002 | 42,94 | 45,04 | 40,91 | 43,61 | +0,33% | 9,62% | 13.194.215 |